Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study
ConditionPolycystic Ovarian Syndrome (PCOS)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age15-25
SponsorUniversity Hospital Erlangen
About this trial
The purpose of the study is to validate recently identified biomarkers for the identification of PCOS in adolecent and young adult women.
Eligibility criteria
Qualifiers
Female subjects age 15-25 years
Signed written informed consent
Disqualifiers
Less than 1 years from onset of menarche
Use of hormonal contraceptives
Documented ongoing pregnancy
Major ovarian abnormalities, including subject with only one ovary, cysts and solid masses > 2 cm as detected by transvaginal ultrasound
Trial design
Treatments tested in this trial
- Not listed
Trial groups
380 Participants
are grouped into 2 trial groupsSponsors and collaborators
University Hospital Erlangen
Lead sponsor
Roche Diagnostics International AG
Collaborator
Source ClinicalTrials.gov